| MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response M Fabbri, A Paone, F Calore, R Galli, E Gaudio, R Santhanam, F Lovat, ... Proceedings of the National Academy of Sciences 109 (31), E2110-E2116, 2012 | 1744 | 2012 |
| Retracted article: EGFR and MET receptor tyrosine kinase–altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers M Garofalo, G Romano, G Di Leva, G Nuovo, YJ Jeon, A Ngankeu, J Sun, ... Nature medicine 18 (1), 74-82, 2012 | 466 | 2012 |
| Modulation of mismatch repair and genomic stability by miR-155 N Valeri, P Gasparini, M Fabbri, C Braconi, A Veronese, F Lovat, B Adair, ... Proceedings of the National Academy of Sciences 107 (15), 6982-6987, 2010 | 456 | 2010 |
| MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2) N Valeri, P Gasparini, C Braconi, A Paone, F Lovat, M Fabbri, KM Sumani, ... Proceedings of the National Academy of Sciences 107 (49), 21098-21103, 2010 | 451 | 2010 |
| miRNA signatures associate with pathogenesis and progression of osteosarcoma KB Jones, Z Salah, S Del Mare, M Galasso, E Gaudio, GJ Nuovo, F Lovat, ... Cancer research 72 (7), 1865-1877, 2012 | 418 | 2012 |
| MicroRNA-135b promotes cancer progression by acting as a downstream effector of oncogenic pathways in colon cancer N Valeri, C Braconi, P Gasparini, C Murgia, A Lampis, V Paulus-Hock, ... Cancer cell 25 (4), 469-483, 2014 | 327 | 2014 |
| Targeted intraoperative radiotherapy impairs the stimulation of breast cancer cell proliferation and invasion caused by surgical wounding B Belletti, JS Vaidya, S D'Andrea, F Entschladen, M Roncadin, F Lovat, ... Clinical Cancer Research 14 (5), 1325-1332, 2008 | 292 | 2008 |
| miR-130a targets MET and induces TRAIL-sensitivity in NSCLC by downregulating miR-221 and 222 M Acunzo, R Visone, G Romano, A Veronese, F Lovat, D Palmieri, ... Oncogene 31 (5), 634-642, 2012 | 246 | 2012 |
| MicroRNAs in the pathogenesis of cancer F Lovat, N Valeri, CM Croce Seminars in oncology 38 (6), 724-733, 2011 | 233 | 2011 |
| Protective role of miR-155 in breast cancer through RAD51 targeting impairs homologous recombination after irradiation P Gasparini, F Lovat, M Fassan, L Casadei, L Cascione, NK Jacob, ... Proceedings of the National Academy of Sciences 111 (12), 4536-4541, 2014 | 230 | 2014 |
| A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis A Vecchione, B Belletti, F Lovat, S Volinia, G Chiappetta, S Giglio, ... Proceedings of the National Academy of Sciences 110 (24), 9845-9850, 2013 | 213 | 2013 |
| Integrated microRNA and mRNA signatures associated with survival in triple negative breast cancer L Cascione, P Gasparini, F Lovat, S Carasi, A Pulvirenti, A Ferro, H Alder, ... PloS one 8 (2), e55910, 2013 | 205 | 2013 |
| Lung cancer exosomes as drivers of epithelial mesenchymal transition MA Rahman, JF Barger, F Lovat, M Gao, GA Otterson, P Nana-Sinkam Oncotarget 7 (34), 54852, 2016 | 191 | 2016 |
| Exosome-derived miR-25-3p and miR-92a-3p stimulate liposarcoma progression L Casadei, F Calore, CJ Creighton, M Guescini, K Batte, OH Iwenofu, ... Cancer research 77 (14), 3846-3856, 2017 | 180 | 2017 |
| Stathmin activity influences sarcoma cell shape, motility, and metastatic potential B Belletti, MS Nicoloso, M Schiappacassi, S Berton, F Lovat, K Wolf, ... Molecular biology of the cell 19 (5), 2003-2013, 2008 | 177 | 2008 |
| microRNA expression profiling identifies a four microRNA signature as a novel diagnostic and prognostic biomarker in triple negative breast cancers P Gasparini, L Cascione, M Fassan, F Lovat, G Guler, S Balci, C Irkkan, ... Oncotarget 5 (5), 1174, 2014 | 167 | 2014 |
| ERK activation globally downregulates miRNAs through phosphorylating exportin-5 HL Sun, R Cui, JK Zhou, K Teng, YH Hsiao, K Nakanishi, M Fassan, Z Luo, ... Cancer cell 30 (5), 723-736, 2016 | 149 | 2016 |
| miR-15b/16-2 deletion promotes B-cell malignancies F Lovat, M Fassan, P Gasparini, L Rizzotto, L Cascione, M Pizzi, ... Proceedings of the National Academy of Sciences 112 (37), 11636-11641, 2015 | 122 | 2015 |
| The insulin-like growth factor receptor I promotes motility and invasion of bladder cancer cells through Akt-and mitogen-activated protein kinase-dependent activation of paxillin D Metalli, F Lovat, F Tripodi, M Genua, SQ Xu, M Spinelli, L Alberghina, ... The American journal of pathology 176 (6), 2997-3006, 2010 | 118 | 2010 |
| p27kip1 functional regulation in human cancer: a potential target for therapeutic designs B Belletti, MS Nicoloso, M Schiappacassi, E Chimienti, S Berton, F Lovat, ... Current medicinal chemistry 12 (14), 1589-1605, 2005 | 116 | 2005 |
